generic drug equivalents

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

63 documents for generic drug equivalents

- Government Of Ontario Ban On Private Label Generics Is Upheld By Court Of Appeal
... and regulatory framework for the sale of drugs in Ontario has been clarified, to some extent, by ... brand name drugs with their generic equivalents and for the listing of drugs covered by the Ontari...
- Mondaq Business Briefing
- Canada Law Articles in English
- Apotex Inc. v. Sanofi-Synthelabo Canada Inc., 2008 SCC 61 (2008)
...Respondents. - and -. Canadian Generic Pharmaceutical Association,. BIOTECanada and Canad...(2d) 73; May & Baker Ltd. v. Boots Pure Drug Co. (1950), 67 R.P.C. 23. Statutes and Regulations...or French equivalents) would in every case and without possibility of er...
- Supreme Court of Canada
- Governments of British Columbia and Québec Announce Changes to Generic Drug Pricing
... cost of brand name drugs for generic equivalents. In a November 5, 2010 notice to generic drug manu...
- Mondaq Business Briefing
- Canada Law Articles in English

- Tories Take Ndp to Task Over Generic Drugs
Some call it a 'delay' -- we call it a 'strategic re-focusing'," [Theresa Oswald] said Friday. "The Manitoba drug formulary needs to be updated on at least a bi-weekly basis as new generics are approved," [Kelvin Goertzen] said. "There is no downside for Manitoba patients or taxpayers to approving the generic drugs more quickly. Tory health critic Kelvin Goertzen says 'not so fast'. He says the delay meant cheaper generic drugs weren't being prescribed to Manitobans as quickly as they were in other provinces. That delay has cost the province millions in potential savings.

... had already approved cheaper generic equivalents that do the same job and which were being used in ...
- Winnipeg Free Press
- August 25, 2009
- Merck & Co., Inc. v. Canada (Attorney General), (1999)
...AND IN THE MATTER OF the Food and Drugs Act, R.S.C. 1985, Chapter F-27 and Division 8 of t... to Nu-Pharm for the drug Nu-Enalapril, a generic version of Merck's patented drug VASOTEC. In my de...and cash equivalents of $2.6 billion U.S. Nu-Pharm sells approximately ...
- Federal Court
- Pharmacapsules @ Gowlings: October 27, 2010
... Contents. Generic Drugs Substantially More Expensive In Canada Than ... just 17 percent of the brand-name equivalents in the U.S. . A variety of federal and provinci...
- Mondaq Business Briefing
- Canada Law Articles in English
- Divergent campaigns towards global health governance: Canadian and U.S. approaches to the global HIV/AIDS pandemic Jeffrey Ayres Patricia Siplon.
... countries' access to affordable generic medications at the same time that the US has aggre... passes bill for industry lobby generic drug with generic export, US impedes industry generic d... four times as much as their generic equivalents, leading activists to argue that the PEPFAR could ...
- Canadian-American Public Policy
- Nbr. 2007, January 2007
- Bristol-Myers Squibb Co. v. Canada (Attorney General), [2005] 1 S.C.R. 533, 2005 SCC 26, 2005 SCC 26 (2005)
...Respondents. - and -. Canadian Generic Pharmaceutical Association,. Pfizer Canada Inc. In... - Notice of compliance - Whether new drug submission falls within scope of s. 5(1.1) of Pate... claimed or by their obvious chemical equivalents; (revendication pour le médicament en soi). "clai...
- Supreme Court of Canada
- Eli Lilly Canada Inc. v. Canada (Minister of Health), 2003 FCA 24 (2003)
..., Eli Lilly developed six ceftazidime drugs. In 1990 and 1992, Eli Lilly obtained notices of c... exception to patent infringement allowing generic competitors to undertake any activities necessary ... claimed or by their obvious chemical equivalents (revendication pour le médicament en soi). . . . ...
- Federal Court of Appeal
- Pfizer Canada Inc. v. Canada (Minister of Health), 2006 FC 210 (2006)
... scheme which incorporates the Food and Drug Regulations , C.R.C., c. 870 and the NOC Regulatio...2. A generic drug manufacturer may seek approval of an ANDS for... claimed or by their obvious chemical equivalents; (revendication pour le médicament en soi). "clai...
- Federal Court